![Al Robichaud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Al Robichaud
Investitore di Private Equity presso
Cure Ventures Management LP
Profilo
Attualmente, Albert J. Robichaud è direttore scientifico di SAGE Therapeutics, Inc. Robichaud ha precedentemente ricoperto la posizione di VP-Chemistry & Pharmacokinetic Sciences presso Lundbeck USA Inc., VP-Chemistry & Pharmacokinetic Sciences presso Lundbeck, Inc. e Senior Director & Head-Neuroscience Discovery presso Wyeth Research. Albert J. Robichaud ha conseguito una laurea presso il Rensselaer Polytechnic Institute e un dottorato presso la University of California, Irvine.
Posizioni attive di Al Robichaud
| Società | Posizione | Inizio |
|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Investitore di Private Equity | 01/01/2024 |
Precedenti posizioni note di Al Robichaud
| Società | Posizione | Fine |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 09/10/2023 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Corporate Officer/Principal | 01/01/2011 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Direttore/Membro del Consiglio | 01/01/2010 |
Lundbeck USA Inc. | Corporate Officer/Principal | - |
Formazione di Al Robichaud
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Lundbeck USA Inc. | |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
